# Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers

> **NCT07632001** · NA · RECRUITING · sponsor: **Reprise Biomedical, Inc.** · enrollment: 180 (estimated)

## Conditions studied

- Diabetic Foot Ulcers (DFUs)
- Diabetic Foot
- Chronic Wounds

## Interventions

- **DEVICE:** Miro3D Wound Matrix
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT07632001
- **Lead sponsor:** Reprise Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632001, "Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*